FORT SAM HOUSTON, JOINT BASE SAN ANTONIO, TX. -The U.S. Army Medical Test and Evaluation Activity (MTEAC) conducted a data collection event (DCE) in support of the whole blood pathogen reduction device (WBPRD) program for the U.S. Army Medical Research Acquisition Activity from 8-12 May 2023. Data was collected at the Nakasero National Blood Bank and the Mulago and Kawempe National Referral Hospitals in Kampala, Uganda.
The WBPRD system is a revolutionary patient care enhancing device designed to eliminate pre-existing contaminates found in whole blood supplies, which subsequently mitigates existing and future patient care challenges associated with life sustaining and stabilization blood supplies.
The MTEAC DCE team visited the Nakasero Blood Bank, Mulago and Kawempe National Referral Hospital Laboratories, working with resident staff to collect logistics data for the period 1 February 2022 through 30 April 2023. Data collected included the number of units of blood produced, transfused, or expired, frequency and consumption rates of consumables, and amounts of general and hazmat waste produced.
The DCE team concluded their mission in Uganda by conducting an out-brief with the program data manager and other staff to summarize data collected and to convey simple ways that on-going data collection efforts may be improved, including redesigning data collection forms, improving data management processes, and invoice storage alternatives at the Nakasero Blood Bank location. The MTEAC will provide a final report of DCE results to the U.S. Army Medical Research Acquisition Activity.
This unique mission underscores the importance of MTEAC’s unbiased approach to data collection and reporting and underscores the Army’s commitment to ensuring that our forces and the greater global medical community receive the very best medical equipment and supplies in the world.
To learn more about MTEAC and their mission visit https://medcoe.army.mil/usamteac-test-and-evaluation